Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,041 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma.
Stern L, Schmidt C, Kocheise L, Joerg V, Casar C, Walter A, Drenth JPH, Papp M, Gatselis NK, Zachou K, Pinter M, Scheiner B, Vogel A, Kirstein MM, Finkelmeier F, Waidmann O, Weinmann A, Milkiewicz P, Thorburn D, Halliday N, Lleo A, Huber S, Dalekos GN, Lohse AW, Wege H, von Felden J, Schulze K. Stern L, et al. Among authors: schmidt c. Ann Hepatol. 2024 Nov-Dec;29(6):101534. doi: 10.1016/j.aohep.2024.101534. Epub 2024 Aug 13. Ann Hepatol. 2024. PMID: 39147132 Free article.
Th17 cell frequency is associated with low bone mass in primary sclerosing cholangitis.
Schmidt T, Schwinge D, Rolvien T, Jeschke A, Schmidt C, Neven M, Butscheidt S, Kriz M, Kunzmann L, Mussawy H, Hubert J, Hawellek T, Rüther W, Oheim R, Barvencik F, Lohse AW, Schramm C, Schinke T, Amling M. Schmidt T, et al. Among authors: schmidt c. J Hepatol. 2019 May;70(5):941-953. doi: 10.1016/j.jhep.2018.12.035. Epub 2019 Jan 11. J Hepatol. 2019. PMID: 30641095
A System to Determine Risk of Osteoporosis in Patients With Autoimmune Hepatitis.
Schmidt T, Schmidt C, Strahl A, Mussawy H, Rolvien T, Jandl NM, Casar C, Oheim R, Schinke T, Lohse AW, Amling M, Schramm C, Barvencik F. Schmidt T, et al. Among authors: schmidt c. Clin Gastroenterol Hepatol. 2020 Jan;18(1):226-233.e3. doi: 10.1016/j.cgh.2019.05.043. Epub 2019 Jun 1. Clin Gastroenterol Hepatol. 2020. PMID: 31163277
Hepatocellular carcinoma: Intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtype.
Krause J, von Felden J, Casar C, Fründt TW, Galaski J, Schmidt C, Jung C, Ittrich H, Weidemann SA, Krech T, Heumann A, Li J, Fischer L, Sauter G, Lohse AW, Wege H, Schulze K. Krause J, et al. Among authors: schmidt c. BMC Cancer. 2020 Nov 23;20(1):1130. doi: 10.1186/s12885-020-07580-z. BMC Cancer. 2020. PMID: 33225916 Free PMC article.
Bone microarchitecture in patients with autoimmune hepatitis.
Schmidt C, Stürznickel J, Strahl A, Oheim R, Weiler-Normann C, Sebode M, Barvencik F, Lohse AW, Schinke T, Amling M, Schramm C, Rolvien T. Schmidt C, et al. J Bone Miner Res. 2021 Jul;36(7):1316-1325. doi: 10.1002/jbmr.4289. Epub 2021 Mar 30. J Bone Miner Res. 2021. PMID: 33724539 Free article.
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease.
Kocheise L, Piseddu I, Vonderlin J, Tjwa ET, Buescher G, Meunier L, Goeggelmann P, Fianchi F, Dumortier J, Riveiro Barciela M, Gevers TJG, Terziroli Beretta-Piccoli B, Londoño MC, Frankova S, Roesner T, Joerg V, Schmidt C, Glaser F, Sutter JP, Fründt TW, Lohse AW, Huber S, von Felden J, Sebode M, Schulze K. Kocheise L, et al. Among authors: schmidt c. Front Immunol. 2024 Jan 10;14:1326078. doi: 10.3389/fimmu.2023.1326078. eCollection 2023. Front Immunol. 2024. PMID: 38268921 Free PMC article.
Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease.
Kocheise L, Piseddu I, Vonderlin J, Tjwa ET, Buescher G, Meunier L, Goeggelmann P, Fianchi F, Dumortier J, Barciela MR, Gevers TJG, Beretta-Piccoli BT, Londoño MC, Frankova S, Roesner T, Joerg V, Schmidt C, Glaser F, Sutter JP, Fründt TW, Lohse AW, Huber S, von Felden J, Sebode M, Schulze K. Kocheise L, et al. Among authors: schmidt c. Front Immunol. 2024 Jan 24;15:1369747. doi: 10.3389/fimmu.2024.1369747. eCollection 2024. Front Immunol. 2024. PMID: 38327519 Free PMC article.
Radiofrequency ablation via catheter and transpapillary access in patients with cholangiocarcinoma (ACTICCA-2 trial) - a multicenter, randomized, controlled, open-label investigator-initiated trial.
Schmidt C, Zapf A, Ozga AK, Canbay A, Denzer U, De Toni EN, Lohse AW, Schulze K, Rösch T, Stein A, Wege H, von Felden J. Schmidt C, et al. BMC Cancer. 2024 Aug 1;24(1):931. doi: 10.1186/s12885-024-12693-w. BMC Cancer. 2024. PMID: 39090600 Free PMC article. Clinical Trial.
Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapy.
Gorgulho J, Loosen SH, Masood R, Giehren F, Pagani F, Buescher G, Kocheise L, Joerg V, Schmidt C, Schulze K, Roderburg C, Kinkel E, Fritzsche B, Wehmeyer S, Schmidt B, Kachel P, Rolling C, Götze J, Busch A, Sinn M, Pereira-Veiga T, Wikman H, Geffken M, Peine S, Matschl U, Altfeld M, Huber S, Lohse AW, Beier F, Brümmendorf TH, Bokemeyer C, Luedde T, von Felden J. Gorgulho J, et al. Among authors: schmidt c. J Exp Clin Cancer Res. 2024 Nov 8;43(1):298. doi: 10.1186/s13046-024-03215-4. J Exp Clin Cancer Res. 2024. PMID: 39511626 Free PMC article.
6,041 results